Trial reportCanadian journal of veterinary research = Revue canadienne de recherche veterinaire2018
Safety evaluation of a new anxiolytic product containing botanicals
Trial report in Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03904511 (Safety, Tolerability and Behavioural Effects of Souroubea-Platanus in Healthy Volunteers), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Safety, Tolerability and Behavioural Effects of Souroubea-Platanus in Healthy Volunteers
Who cites it
4 citing papers in PubMed, 6 citations in OpenAlex.
- Mini review: Ethnopharmacology and phytochemistry of the tropical American family Marcgraviaceae.Frontiers in pharmacology · 2025Review
- Efficacy of Souroubea-Platanus Dietary Supplement Containing Triterpenes in Beagle Dogs Using a Thunderstorm Noise-Induced Model of Fear and Anxiety.Molecules (Basel, Switzerland) · 2021Article
- Extract and Active Principal of the Neotropical VineFrontiers in pharmacology · 2019Article
- New Botanical Anxiolytics for Use in Companion Animals and Humans.The AAPS journal · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Separation anxiety and noise aversion are common behavioral problems in dogs. They elicit fear responses such as cowering, seeking out the owner, and attempting to escape. This can result in property damage, injury to the dog, and disruption of the owner-pet bond, possibly leading to pet abandonment or euthanasia. A novel botanical anxiolytic product was evaluated for safety in dogs as the target animal species. Its intended use is for the treatment and prevention of anxiety and noise aversion in dogs. It contains a defined mixture of
Indexed as
Identifiers
29382964PMC5764046W2980481950What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.